35th
largest pharmaceutical
group worldwide
2nd
largest French
pharmaceutical group
20%
Over 20% of revenue from brand-name
medicines invested in R&D each year
70
Over 70 scientific partnerships and
collaborations in 2024/2025
20 000
employees in
130 countries
96.5%
of the active ingredients used
in the Group’s brand-name medicines
are produced by Servier in France
177
international patient organizations
collaborated with Servier in 2023